Nav: Home

Cell death may be triggered by 'hit-and-run' interaction

April 09, 2019

A 'hit-and-run' interaction between two proteins could be an important trigger for cell death, according to new research from Walter and Eliza Hall Institute researchers.

The researchers investigated the chain of events that activates the protein BAX, which is a crucial driver of apoptosis, the major form of cell death. Addressing a long-standing question in the field, they discovered that BAX is activated for cell death by transient interactions with so-called 'BH3-only' proteins at two distant sites on BAX.

The research, led by Dr Michael Dengler and Professor Jerry Adams, was published today in the journal Cell Reports.

At a glance
  • Activation of the protein BAX is a key step in apoptosis, the programmed death of cells.
  • Our researchers revealed a previously controversial 'hit-and-run' interaction between BAX and 'BH3-only' proteins that initiates the conversion of BAX into a lethal protein for cells.
  • The discovery, which clarifies a long-standing question in apoptosis research, could underpin the development of new approaches to trigger or prevent the death of cells in certain diseases.
Triggering cell death

Apoptosis is the major way our bodies remove damaged or unwanted cells. Many different stimuli trigger apoptosis by turning on cell signalling pathways that activate BAX and its close relative BAK. Activated BAX and BAK create holes in the cell's energy factories, the mitochondria. Once mitochondria are damaged, cells are compelled to die.

Professor Adams said a long-standing question in apoptosis research had been how BAX is triggered to move to mitochondria once cell death is triggered. "The events activating BAX once it has embedded on the surface membrane of mitochondria have been well-characterised - we know that death-inducing BH3-only proteins bind to BAX, changing its shape to damage the mitochondrial membrane," he said.

"There had been hints that BH3-only proteins are also the signal for BAX to move from its location in a healthy cell's cytosol - the liquid interior of the cell - to the mitochondria, but the experimental data supporting this were controversial and weak."

Two-step activation

To understand how BAX interacts with BH3-only proteins, Dr Dengler and colleagues strategically altered different regions of BAX, subtly changing the protein's structure. By comparing the behaviour of these mutant forms of BAX with that of normal, unmutated BAX, they could determine the function of different regions of BAX, he said.

"We discovered that two different parts of BAX could bind to BH3-only proteins," he said. "Intriguingly, these sites functioned at different stages of BAX activation.

"One site prompted BAX to move to the mitochondrial membrane. Binding of BH3-only proteins to this site on BAX changed BAX's structure, releasing a 'tail' that anchors BAX to mitochondria. When BH3- only proteins bound the other site on BAX, BAX became able to damage the mitochondria."

These two distinct steps in BAX activation had not previously been clearly distinguished.

"The first, early activation step had never been well characterised, because it appears to involve a transient 'hit-and-run' interaction between BAX and a BH3-only protein. We think this first step might be a way that BAX activation can be fine-tuned," Dr Dengler said.

The research involved collaborations with structural biology and proteomics researchers at the Institute, aided by the Australian Synchrotron and the CSIRO Collaborative Crystallisation Centre. "Structural biology and proteomics were critical technologies for understanding how BAX is activated," Dr Dengler said.

As well as explaining a key detail in how cell death is executed, the research may in the future lead to new classes of drugs that modify BAX function.

"BAX is a key mediator of cell death, and many major diseases involve either too little or too much cell death. Our discovery may eventually underpin the search for drugs that promote apoptosis by activating BAX, which may have potential for treating cancer. Conversely, drugs that block BAX activation could help to prevent the harmful cell death that occurs in neurodegenerative disorders or stroke," Professor Adams said.
-end-
The research was supported by the Australian National Health and Medical Research Council, the USbased Leukemia and Lymphoma Society and the Victorian Government. For more information contact the Institute media office on 0475 751 811 or communityrelations@wehi.edu.au

Walter and Eliza Hall Institute

Related Mitochondria Articles:

Mitochondria-targeted antioxidant SkQ1 helps to treat diabetic wounds
Members of the Faculty of Biology and A.N. Belozersky Institute of Physico-Chemical Biology, a unit of the Lomonosov Moscow State University, have tested on a mouse model a mitochondria-targeted antioxidant, helping to treat diabetic wounds.
Mitochondria targeting anti-tumor compound
Researchers from Kumamoto University in Japan have found that the compound folic acid-conjugated methyl-BETA-cyclodextrin (FA-M-BETA-CyD) has significant antitumor effects on folate receptor-ALPHA-expressing (FR-ALPHA (+)) cancer cells.
Closing the gate to mitochondria
A team of researchers develops a new method that enables the identification of proteins imported into mitochondria.
Elucidated connection between renal failure and 'bad' mitochondria described
Biologists from the A.N. Belozersky Institute of Physico-Chemical Biology, a unit of the Lomonosov Moscow State University suggested the approach to prevent kidney injury after ischemia.
How exercise -- interval training in particular -- helps your mitochondria stave off old age
Researchers have long suspected that the benefits of exercise extend down to the cellular level, but know relatively little about which exercises help cells rebuild key organelles that deteriorate with aging.
Cell disposal faults could contribute to Parkinson's, study finds
A fault with the natural waste disposal system that helps to keep our brain cell 'batteries' healthy may contribute to neurodegenerative disease, a new study has found.
Sex cells evolved to pass on quality mitochondria
Mammals immortalize their genes through eggs and sperm to ensure future generations inherit good quality mitochondria to power the body's cells, according to new UCL research.
Newly identified pathway in mitochondria fuels tumor progression across cancer types
Scientists at The Wistar Institute have identified a novel protein pathway across several types of cancer that controls how tumor cells acquire the energy necessary for movement, invasion and metastasis.
Collapse of mitochondria-associated membrane in ALS
Mitochondria-associated membrane (MAM) is a contacting site of endoplasmic reticulum and mitochondria, and plays a key role in cellular homeostasis.
New research on the muscles of elite athletes: When quality is better than quantity
A Danish-Swedish research team working on a project led by University of Southern Denmark has discovered that muscle endurance is not only determined by the number of mitochondria, but also their structure.

Related Mitochondria Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Setbacks
Failure can feel lonely and final. But can we learn from failure, even reframe it, to feel more like a temporary setback? This hour, TED speakers on changing a crushing defeat into a stepping stone. Guests include entrepreneur Leticia Gasca, psychology professor Alison Ledgerwood, astronomer Phil Plait, former professional athlete Charly Haversat, and UPS training manager Jon Bowers.
Now Playing: Science for the People

#524 The Human Network
What does a network of humans look like and how does it work? How does information spread? How do decisions and opinions spread? What gets distorted as it moves through the network and why? This week we dig into the ins and outs of human networks with Matthew Jackson, Professor of Economics at Stanford University and author of the book "The Human Network: How Your Social Position Determines Your Power, Beliefs, and Behaviours".